DAVID HUNTSMAN, M.D.
MD, FRCPC, FCCMG
Director & Co-Founder
David Huntsman brings world-leading expertise and experience in the application of genomics into clinical practice.
Dr. Huntsman’s expertise is in the translation of genomics into assays leading into improved cancer control, which demands complimentary expertise in the development and delivery of novel assays as well as discovery genomics. In addition to leading cutting edge research in the discovery and development of biomarkers and therapeutic targets for ovarian and rare cancers, Dr. Huntsman directs the cutting edge CAP/CLIA certified Centre for Translational and Applied Genomics (CTAG), which has been instrumental to bringing new diagnostic assays into clinical practice.
Dr. Huntsman’s group has a long track record of taking discoveries from basic genomic research into large cohorts of clinically annotated samples to determine their clinical relevance.